Norway· NO-ID_90359F47-0F14-4A1A-935C-67E514E4EDD8
Cystadrops
A mercaptamine product containing mercaptamine, registered in Norway by Recordati Rare Diseases. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA21 (mercaptamine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Mercaptamine · ATC S01XA21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Mercaptamine
- Manufacturer
- Recordati Rare Diseases
- Country
- Norway (NO)
- ATC code
- S01XA21
- ATC class
- Mercaptamine
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- gtin3663502003626
- no_merkevare_idID_90359F47-0F14-4A1A-935C-67E514E4EDD8
- no_varenummer1619814 x 5NOK 59059.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- SwitzerlandCystadrops 3.8 mg/ml, AugentropfenRECORDATI AG
- FinlandCystadropsRecordati Rare Diseases
- FranceCYSTADROPS 3,8 mg/mL, collyre en solutionRECORDATI RARE DISEASES
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
- NetherlandsCystadrops 3,8 mg/ml oogdruppels, oplossingOrphan Europe SARL
- PolandCystadropsRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d65571ac-cb2d-4ca9-81db-73efb3e6fe3c GET /v1/drugs/d65571ac-cb2d-4ca9-81db-73efb3e6fe3c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Merkaptamin",
"merkevare_id": "ID_90359F47-0F14-4A1A-935C-67E514E4EDD8",
"name_form_strength": "Cystadrops øyedr, oppl 3,8 mg/ml",
"prescription_group": "C"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.